Over 30,000 participate in human trials for Cuba’s COVID-19 vaccine

By Benjamin Flowers: Prensa Latina is reporting that nearly 35,000 people have received Cuba’s Soberana 02 COVID-19 vaccine as a part of Phase III clinical trial.

Finlay Vaccine Institute (IFV) Deputy Director Yuri Valdes informed that 44,010 volunteers are expected to complete the trial on Wednesday, March 31 and that a trial could soon start which sees the vaccine being tested on a population of volunteers below 18 years of age.

The report said that Soberana 02 Phase III trials are aiming to demonstrate the vaccine’s efficacy through two vaccination programs: one with two doses of the shot and a third booster dose with Soberana Plus, also developed by the IFV, will be added.

“In addition to the volunteers who have already received the vaccine in that period, more than 13,000 Cuban health and biopharmaceutical workers were vaccinated this week and included in the intervention trial that started on Monday, March 22, in which 150,000 individuals must be vaccinated,” Prensa Latina noted.

As a routine part of the clinical-epidemiological testing process, volunteers will be exposed to the SARS-CoV-2 coronavirus, the pathogen that causes COVID-19, in real situations of community contagion and the effects of vaccination in population sectors with high risk, disease and spread of the pandemic, to determine the level of protection the vaccine offers.

Advertise with the mоѕt vіѕіtеd nеwѕ ѕіtе іn Belize ~ We offer fully customizable and flexible digital marketing packages. Your content is delivered instantly to thousands of users in Belize and abroad! Contact us at mаrkеtіng@brеаkіngbеlіzеnеwѕ.соm or call us at 501-612-0315.

© 2021, BreakingBelizeNews.com. Content is copyrighted and requires written permission for reprinting in online or print media. Theft of content without permission/payment is punishable by law.